Fludara Clinical Trials

2 actively recruiting trials across 2 locations

No change since May 2026

Also known as: Fludarabine, fludarabine

Pipeline

Phase 1: 2

Top Sponsors

Celyad Oncology SA1
Baylor College of Medicine1

Indications

Cancer2
Liver Disease1
Yolk Sac Tumor1
Wilms Tumor1
Malignant Rhabdoid Tumor1

Jacksonville, Florida1 trial

Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02

Mayo Clinic Cancer Center

Phase 1

Houston, Texas1 trial

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

Texas Children's Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.